Skip to content

Quadratus Lumborum Block : Effect on Acute Pain and Quality of Recovery After Laparoscopic Adrenalectomy

Quadratus Lumborum Block : Effect on Acute Pain and Quality of Recovery After Laparoscopic Adrenalectomy

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03844477
Enrollment
25
Registered
2019-02-18
Start date
2019-02-16
Completion date
2019-05-15
Last updated
2019-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic Adrenalectomy, Nerve Block, Pain Management

Brief summary

This prospective, randomized ,control study aims to compare the analgesic effect,quality of recovery, length of hospital stay ,et al. between single-injection QLB(quadratus lumborum block)+general anesthesia (GA) and general anesthesia (GA) alone in patients undergoing laparoscopic adrenalectomy.

Interventions

Inject 0.4ml/kg 0.5% ropivacaine between quadratus lumborum and psoas major without continuous local infusion Device: Ultrasound Scanner The curved (C1-5) probe of Ultrasound Scanner is used for scan Device: PAJUNK StimuLong Drug: single dose ropivacaine 0.4ml/kg 0.5% ropivacaine given immediately after the correct position of the tip of the needle has been verified.

PROCEDUREPlacebo control

Inject 0.4ml/kg saline between quadratus lumborum and psoas major without continuous local infusion Device: Ultrasound Scanner The curved (C1-5) probe of Ultrasound Scanner is used for scan Device: PAJUNK StimuLong Drug: single dose 0.4ml/kg 0.9% NS. given immediately after the correct position of the tip of the needle has been verified.

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-70 yrs * American Society of Anesthesiologists physical statusⅠ-Ⅲ * Undergo laparoscopic adrenalectomy * Informed consent

Exclusion criteria

* A known allergy to the drugs being used * Coagulopathy, on anticoagulants * Analgesics intake, history of substance abuse * Participating in the investigation of another experimental agent * Inability to properly describe postoperative pain to investigators (eg, language barrier, neuropsychiatric disorder)

Design outcomes

Primary

MeasureTime frame
pain numeric rating scale (NRS, 0-10)pain score at activity at 12 hours after surgeryAt 12hours after the surgery

Secondary

MeasureTime frameDescription
incidence of postoperative nausea and vomiting (PONV)within 24 postoperative hours
ambulation timewithin5 days after surgery
time of restart anal exhaustwithin 5 days after surgery
The pain scores at rest determined by the numeric rating scale (NRS, 0-10)At 2,4, 8, 12,24 ,48,72hours after the surgery
patient's satisfaction with anesthesia and analgesia48 hours after surgeryuse the Chinese version Bauer questionnaire to assess the patient satisfaction with anesthesia and analgesia
The pain scores at activity determined by the numeric rating scale (NRS, 0-10)At 2,4, 8, 24 ,48,72hours after the surgery
Postoperative length of hospital stayup to2 weeks after surgery

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026